The Emerson Exchange conference October 6-10 in Orlando, Florida USA is rapidly approaching. I caught up with Emerson's Michalle Adkins who mentioned that her team of Life Sciences consultants would be highlighting the enablement of release by exception. Although...
In 2011, the U.S. Food & Drug Administration (FDA) published their Guidance for Industry – Process Validation: General Principles and Practices. A PharmManufacturing.com article, A Framework for Technology Transfer to Satisfy the Requirements of the New Process...
In the 4:42 video, Life Science Drug Process Development and Manufacturing, Emerson's Gary Mitchell highlights the changes occurring for pharmaceutical and biotech manufacturers. Gary opens noting how these manufacturers are challenged to respond to new methods for...
Author: Michalle Adkins I often get asked, "So, what do you do for a living?" Boy is that a loaded question. When I say that I manage a group of Life Sciences Industry Consultants for Emerson—that really does not help to answer the question. Hmmm, how do I describe...
This week, the Bio International Convention (Bio 2014) is happening in San Diego, California. Several of Emerson's Life Sciences consultants, including Zuwei Jin, are there to discuss some of the issues and trends in pharmaceutical and biotech manufacturing processes...
Author: Gary Mitchell The Emerson Life Sciences Industry Solutions Group consultants, including Saroj Patnaik, Michalle Adkins, Jonathan Lustri, Zuwei Jin and me, will be joining Hillary Clinton, Sir Richard Branson and over 15,000 other attendees from Biotech and...
Pharmaceutical and biotech manufacturing processes are complex and require well integrated and documented flows of information from upfront forecast demand and customer orders through the production process to inventory receipt and order fulfillment. The components...
For mature markets with retiring "baby boomers", how do we best facilitate the knowledge transfer to the next generation of instrumentation and automation professionals? Emerson's Gary Mitchell, a Senior Life Sciences Industry Consultant, shares some of his career...
Emerson's Jonathan Lustri explores the trend towards continuous manufacturing for solid dose pharmaceuticals and the technologies and practices that make this possible. This past year I have become aware of a very big change that is coming to the pharmaceutical...
While integration technologies have helped bridge "islands of automation" over the years, some process manufacturers still have parts of their automated processes disconnected from the rest. Emerson's Gary Mitchell, a senior industry consultant on the Life Sciences...
In two very different industries, I have some updates to share from Emerson consultants. On the reliability front, when we last checked in with Emerson's Richard Barnes, a Senior Asset Optimization Consultant, he was at a refinery located on the Black Sea, assisting...
Highly regulated industries, such as pharmaceutical and biotech manufacturing, face a myriad of compliance issues, which vary by region of the world and continuously involve. Emerson's Heather Schwalje presented Regulatory Drivers- GMPs 21st Century to Life Science...
We invite you to follow us on Facebook, LinkedIn, Twitter and YouTube to stay up to date on the latest news, events and innovations that will help you face and solve your toughest challenges.
Just post a link to the entry and send us a quick note so we can share your work. Thank you very much.
Our Global Community
Emerson Exchange 365
This blog features expert perspectives from Emerson's automation professionals on industry trends, technologies, and best practices. The information shared here is intended to inform and educate our global community of users and partners.